Will These 3 Dividend Stocks Impress Investors This Earnings Season?

Earnings season already has produced its fair share of surprises, but big pharma's hardly even broken out of the gate so far. However, a trio of major drugmakers are set to release their quarterly results in the next two weeks, and all eyes in the sector will be on Bristol-Myers Squibb (NYSE: BMY  ) , Merck (NYSE: MRK  ) , and Pfizer (NYSE: PFE  ) to see how these companies are overcoming patent expirations, declining sales, and pipeline development to keep investors profiting in the long term. A key part of that profit is, of course, their strong dividend payouts -- Bristol yields 2.8%, Merck 3.0%, and Pfizer 3.4%.

Each of these three big pharma giants has dealt with tough patent blows, from Pfizer's loss of blockbuster drug Lipitor's exclusivity to Bristol's struggles since it lost patent protection on former star therapy Plavix. However, new drugs are rising to build foundations at these companies, from Merck's diabetes duo of Januvia and Janumet to Bristol and Pfizer's big-potential blood thinner Eliquis, which has struggled to a slow start out of the gate so far in its young life.

Can these pharmaceutical titans pass a clean bill of health this earnings season? Find out in the video below, where Motley Fool contributor Dan Carroll shows you what you need to watch for in each of these three companies' earnings results -- and whether these stocks can mount a rally through 2014.

9 more dividend stocks investors love
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That’s beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor’s portfolio. To see our free report on these stocks, just click here now.

 


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2925315, ~/Articles/ArticleHandler.aspx, 9/19/2014 4:09:43 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement